The dermatology-specific body of knowledge that is leveraged in our development programs can be accessed for technical evaluation of investment opportunities. Members of our senior staff are available to confidentially assess technologies for clients considering licensing or acquisition opportunities. We routinely support dermatology companies, biotechnology companies, investment banks and venture capitalists in assessment of dermatology-related technology.